FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1000811000001108: Flucloxacillin 250mg/5ml oral suspension 100 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21984501000001113 Flucloxacillin 250mg/5ml oral suspension 100 ml (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21984601000001112 Flucloxacillin 250mg/5ml oral suspension 100 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Flucloxacillin 250mg/5ml oral suspension 100 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Is pack of Product containing precisely flucloxacillin (as flucloxacillin magnesium) 50 milligram/1 milliliter conventional release oral suspension false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has active ingredient Flucloxacillin magnesium false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has manufactured dose form Conventional release oral suspension false Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has VMP Product containing precisely flucloxacillin (as flucloxacillin magnesium) 50 milligram/1 milliliter conventional release oral suspension true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has specific active ingredient Flucloxacillin magnesium true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Flucloxacillin 250mg/5ml oral suspension 100 ml Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Floxapen 250mg/5ml syrup (GlaxoSmithKline) 100 ml Is a True Flucloxacillin 250mg/5ml oral suspension 100 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start